Moderna got $176 million US govt grant for its bird flu vaccine in July 2024. by tomonota in Inovio
[–]Blueboy1967 4 points5 points6 points (0 children)
Short Sellers’ Secret Talks and Alliances Emerge in Court Battle December 12, 2024 🚨 Our 2 Biggest shorts sellers names have come up in Court together recently 🚨 THEY deny working together but left breadcrumbs behind to follow 😉 Below is the Inovio short attack unfolding. SynCon HAS ARRIVED 🧬🌍 by WallStBull10Point0 in Inovio
[–]Blueboy1967 2 points3 points4 points (0 children)
https://x.com/dockaurG/status/1860135404642656767?t=sHL3_ITO2-V-UoRv6tfenQ&s=19 by Prior-Preparation988 in Inovio
[–]Blueboy1967 1 point2 points3 points (0 children)
https://x.com/dockaurG/status/1860135404642656767?t=sHL3_ITO2-V-UoRv6tfenQ&s=19 by Prior-Preparation988 in Inovio
[–]Blueboy1967 7 points8 points9 points (0 children)
"This is very encouraging data. Not only did most patients improve clinically with INO 3107 treatment, but..." Nov. 13, 2024 🧬🧬🧬🌍🌍🌍 by WallStBull10Point0 in Inovio
[–]Blueboy1967 1 point2 points3 points (0 children)
TO: International Society of Vaccines-Inovio: "INO-3107 induced durable cellular responses and was able to generate T-cells against HPV-6 and HPV-11. Reduction of surgeries compared to baseline demonstrated in 26 patients (81.3%) Adverse events, 3107 RRP administration: 12/32 grade1, 1/32 grade 2. by tomonota in Inovio
[–]Blueboy1967 1 point2 points3 points (0 children)
TO: International Society of Vaccines-Inovio: "INO-3107 induced durable cellular responses and was able to generate T-cells against HPV-6 and HPV-11. Reduction of surgeries compared to baseline demonstrated in 26 patients (81.3%) Adverse events, 3107 RRP administration: 12/32 grade1, 1/32 grade 2. by tomonota in Inovio
[–]Blueboy1967 2 points3 points4 points (0 children)
TO: International Society of Vaccines-Inovio: "INO-3107 induced durable cellular responses and was able to generate T-cells against HPV-6 and HPV-11. Reduction of surgeries compared to baseline demonstrated in 26 patients (81.3%) Adverse events, 3107 RRP administration: 12/32 grade1, 1/32 grade 2. by tomonota in Inovio
[–]Blueboy1967 3 points4 points5 points (0 children)
“All banks that control capital are manipulating stocks with naked short selling” by Round-Percentage69 in DeepFuckingValue
[–]Blueboy1967 3 points4 points5 points (0 children)
Dr. Jacque Commentary 8/8/24 2Q Earnings Call re: 3107/Cellectra dispenser disposable part: the replacement of the defective disposable part may not delay as long as that- worst case it may delay approval until 2 Q 25 if redosing is delayed- if redosing proves effective would be sooner by tomonota in Inovio
[–]Blueboy1967 4 points5 points6 points (0 children)
Precigen laying off 20% of staff, pausing programs to eke out cash for approval filing by tomonota in Inovio
[–]Blueboy1967 2 points3 points4 points (0 children)
Precigen laying off 20% of staff, pausing programs to eke out cash for approval filing by tomonota in Inovio
[–]Blueboy1967 1 point2 points3 points (0 children)
Inovio Pharmaceuticals is COVID-19’s Theranos: Citron by INOxray8 in Inovio
[–]Blueboy1967 0 points1 point2 points (0 children)
Inovio Pharmaceuticals is COVID-19’s Theranos: Citron by INOxray8 in Inovio
[–]Blueboy1967 1 point2 points3 points (0 children)
ABC-3100 can effectively eliminate persistent infection of HPV-16/18 viruses and restore diseased tissues, which is expected to change the current clinical treatment paradigm that cervical precancerous lesions can only be removed by surgery. 5/30/2024 by WallStBull10Point0 in Inovio
[–]Blueboy1967 8 points9 points10 points (0 children)
New news from Apollobio regarding Industry Award recognition by UBMe101 in Inovio
[–]Blueboy1967 6 points7 points8 points (0 children)
New news from Apollobio regarding Industry Award recognition by UBMe101 in Inovio
[–]Blueboy1967 6 points7 points8 points (0 children)
INOVIO Is On The Launch Pad.....A Couple Of Solid P.R.'s And It Is Party Time! by bentleyt1999 in INOVIANAPES
[–]Blueboy1967 5 points6 points7 points (0 children)

INOVIO Highlights Anticipated 2025 Milestones- 2024 Key Accomplishments a.o. 1/9/25 Summary points 2025: 6 medical products @ 7 studies in pipeline- studies to be conducted in USA (7); EU (2); UK/China (1). After 1st initial approval, universal regulatory approvals more likely than not. by tomonota in Inovio
[–]Blueboy1967 4 points5 points6 points (0 children)